Ginkgo Bioworks Holdings Inc (NYSE: DNA) is 13.14% higher on its value in year-to-date trading and has touched a low of $5.26 and a high of $64.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DNA stock was last observed hovering at around $11.20 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $11.11, the stock is 10.09% and 23.64% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.42 million and changing -0.80% at the moment leaves the stock -32.71% off its SMA200. DNA registered -82.20% loss for a year compared to 6-month loss of -14.56%. The firm has a 50-day simple moving average (SMA 50) of $8.927 and a 200-day simple moving average (SMA200) of $16.66975.
The stock witnessed a -4.72% gain in the last 1 month and extending the period to 3 months gives it a 33.21%, and is 13.14% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.74% over the week and 11.87% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $638.59M and $217.95M in sales. Profit margin for the company is -298.78%. Distance from 52-week low is 111.22% and -82.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.37%).
The EPS is expected to grow by 45.22% this year
227.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 73.23% of the company’s shares. The shares outstanding are 41.37M, and float is at 36.49M with Short Float at 19.66%. Institutions hold 68.34% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 7.1383 of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.7063 and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.485 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
The most recent transaction is an insider sale by Coen Steven P.,. SEC filings show that Coen Steven P. sold 324 shares of the company’s common stock on Jan 06 ’25 at a price of $11.72 per share for a total of $3797.0. Following the sale, the insider now owns 7288.0 shares.
Ginkgo Bioworks Holdings Inc disclosed in a document filed with the SEC on Jan 06 ’25 that Dmytruk Mark E. sold a total of 645 shares of the company’s common stock. The trade occurred on Jan 06 ’25 and was made at $11.72 per share for $7558.0. Following the transaction, the insider now directly holds 33216.0 shares of the DNA stock.
Still, SEC filings show that on Jan 08 ’25, Che Austin (Officer) Proposed Sale 99 shares at an average price of $10.81 for $1070.0. The insider now directly holds shares of Ginkgo Bioworks Holdings Inc (DNA).
